Metabolic tumour volume of anal carcinoma on 18FDG PET/CT before combined radiochemotherapy is the only independant determinant of recurrence free survival
by Siamak Mohammadkhani Shali
No club is reading this yet — be the first to start one
Discuss Metabolic tumour volume of anal carcinoma on 18FDG PET/CT before combined radiochemotherapy is the only independant determinant of recurrence free survival with other readers
Join or start a book club for Metabolic tumour volume of anal carcinoma on 18FDG PET/CT before combined radiochemotherapy is the only independant determinant of recurrence free survival on Readfeed. Live chat, shared reading progress, and AI discussion questions — free to get started.
Frequently asked questions
How do I join a book club for Metabolic tumour volume of anal carcinoma on 18FDG PET/CT before combined radiochemotherapy is the only independant determinant of recurrence free survival?
Sign up free on Readfeed, then browse public clubs or start your own club with Metabolic tumour volume of anal carcinoma on 18FDG PET/CT before combined radiochemotherapy is the only independant determinant of recurrence free survival as the current read. Invite friends with a share link and discuss together with live chat and AI discussion questions.
Can I discuss Metabolic tumour volume of anal carcinoma on 18FDG PET/CT before combined radiochemotherapy is the only independant determinant of recurrence free survival with other readers online?
Yes. Readfeed book clubs let you chat live, share progress, and join discussions about Metabolic tumour volume of anal carcinoma on 18FDG PET/CT before combined radiochemotherapy is the only independant determinant of recurrence free survival with readers worldwide — whether your club is virtual, in-person, or hybrid.
Is Readfeed free?
Yes. Creating an account and joining book clubs is free. Sign up to find readers who love the same books and start discussing today.